当前位置:首页 - 行情中心 - 诚达药业(301201) - 财务分析 - 现金流量表

诚达药业

(301201)

  

流通市值:32.25亿  总市值:45.97亿
流通股本:1.09亿   总股本:1.55亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金209,499,121.9863,888,356.57423,016,713.16332,325,333.23
  收到的税费返还2,388,382.8630.67-285,766.83
  收到其他与经营活动有关的现金8,579,640.392,865,624.1817,379,987.617,876,964.67
  经营活动现金流入小计220,467,145.2366,754,011.42440,396,700.76350,488,064.73
  购买商品、接受劳务支付的现金124,165,522.0855,909,701.84194,033,908.41180,788,256.17
  支付给职工以及为职工支付的现金47,336,951.3921,095,032.4281,606,213.7261,628,904.3
  支付的各项税费5,440,443.484,683,368.7719,728,524.8814,221,923.2
  支付其他与经营活动有关的现金20,133,318.028,027,478.95116,379,677.9735,925,934.24
  经营活动现金流出小计197,076,234.9789,715,581.98411,748,324.98292,565,017.91
  经营活动产生的现金流量净额23,390,910.26-22,961,570.5628,648,375.7857,923,046.82
二、投资活动产生的现金流量:
  收回投资收到的现金3,460,022,696.251,838,022,696.253,129,014,887.79972,158,316.79
  取得投资收益收到的现金9,904,454.464,092,635.6630,786,457.2323,819,115.33
  处置固定资产、无形资产和其他长期资产收回的现金净额231,72556,0002,148,530.972,269,039.99
  投资活动现金流入小计3,470,158,875.711,842,171,331.913,161,949,875.99998,246,472.11
  购建固定资产、无形资产和其他长期资产支付的现金74,434,947.5934,875,665.02286,364,987.86185,226,415.35
  投资支付的现金2,785,000,0001,500,000,0004,085,063,218.151,672,150,547.96
  投资活动现金流出小计2,859,434,947.591,534,875,665.024,371,428,206.011,857,376,963.31
  投资活动产生的现金流量净额610,723,928.12307,295,666.89-1,209,478,330.02-859,130,491.2
三、筹资活动产生的现金流量:
  吸收投资收到的现金--380,000380,000
  其中:子公司吸收少数股东投资收到的现金--380,000-
  取得借款收到的现金8,079,3008,079,30080,118,379.9-
  收到其他与筹资活动有关的现金--0-
  筹资活动现金流入小计8,079,3008,079,30080,498,379.9380,000
  分配股利、利润或偿付利息支付的现金1,237,233.96606,130.5730,548,288.7729,099,476.74
  支付其他与筹资活动有关的现金--57,073,347.6757,073,347.67
  筹资活动现金流出小计1,237,233.96606,130.5787,621,636.4486,172,824.41
  筹资活动产生的现金流量净额6,842,066.047,473,169.43-7,123,256.54-85,792,824.41
四、汇率变动对现金及现金等价物的影响683,532.64225,712.162,205,466.91,807,603.45
五、现金及现金等价物净增加额641,640,437.06292,032,977.92-1,185,747,743.88-885,192,665.34
  加:期初现金及现金等价物余额176,941,170.9178,463,170.91,362,688,914.781,362,688,914.78
  期末现金及现金等价物余额818,581,607.96470,496,148.82176,941,170.9477,496,249.44
补充资料:
  净利润12,995,531.41--27,639,162.41-
  资产减值准备4,184,500.97-3,085,916.41-
  固定资产和投资性房地产折旧34,430,870.83-45,659,601.77-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧34,430,870.83-45,659,601.77-
  无形资产摊销770,048.1-1,498,414.21-
  长期待摊费用摊销8,624,562.17-14,247,163.55-
  处置固定资产、无形资产和其他长期资产的损失-37,332.75--204,739.69-
  固定资产报废损失445,480.02-2,531,986.26-
  公允价值变动损失-2,964,478.63--1,603,689.96-
  财务费用-755,430.47--1,910,128.64-
  投资损失-6,273,243.09--30,786,457.23-
  递延所得税-992,744.01--441,741.43-
  其中:递延所得税资产减少-489,061.73--378,846.37-
    递延所得税负债增加-503,682.28--62,895.06-
  存货的减少-20,844,628.7--12,589,910.61-
  经营性应收项目的减少-22,511,366.5--35,468,675.59-
  经营性应付项目的增加10,548,886.24-71,648,899.14-
  其他5,770,254.67-620,900-
  现金的期末余额818,581,607.96-176,941,170.9-
  减:现金的期初余额176,941,170.9-1,362,688,914.78-
  现金及现金等价物的净增加额641,640,437.06--1,185,747,743.88-
公告日期2025-08-262025-04-252025-04-252024-10-29
审计意见(境内)标准无保留意见
TOP↑